Literature DB >> 22210638

Design challenges facing clinical trials of the effectiveness of new HIV-prevention technologies.

Anneke C Grobler1, Salim S Abdool Karim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22210638      PMCID： PMC3442788          DOI： 10.1097/QAD.0b013e3283509a29

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Design and analysis of non-inferiority mortality trials in oncology.

Authors:  Mark Rothmann; Ning Li; Gang Chen; George Y H Chi; Robert Temple; Hsiao-Hui Tsou
Journal:  Stat Med       Date:  2003-01-30       Impact factor: 2.373

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

Review 3.  Weighing the gold in the gold standard: challenges in HIV prevention research.

Authors:  Nancy S Padian; Sandra I McCoy; Jennifer E Balkus; Judith N Wasserheit
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

4.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

5.  Can further placebo-controlled trials of antiretroviral drugs to prevent sexual transmission of HIV be justified?

Authors:  Louise Kuhn; Ida Susser; Zena Stein
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

6.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245
  6 in total
  4 in total

Review 1.  Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.

Authors:  Q Abdool Karim; C Baxter; S Abdool Karim
Journal:  BJOG       Date:  2014-10       Impact factor: 6.531

2.  Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.

Authors:  Liza Dawson; Sheryl Zwerski
Journal:  Bioethics       Date:  2014-09-17       Impact factor: 1.898

3.  A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.

Authors:  Roman Shrestha; Archana Krishnan; Frederick L Altice; Michael Copenhaver
Journal:  Contemp Clin Trials       Date:  2015-08-05       Impact factor: 2.226

4.  A typology of structural approaches to HIV prevention: a commentary on Roberts and Matthews.

Authors:  Alexander C Tsai
Journal:  Soc Sci Med       Date:  2012-07-31       Impact factor: 5.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.